Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,009,097
-$2,682,668 QoQ
Shares Held
457,907
-27.6% QoQ
Ownership
0.329%
of shares outstanding
% of Portfolio
1.89%
of 13F equity value
Holder Rank
#63
of 477 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Dec 31, 2024CallValue
$710,304
CallShares
15,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. CYTK ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,804,703 | $240,494,721 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
960,863 | $117,782,586 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,157,008 | $111,726,513 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,330,716 | $89,802,487 | |
| 5 | ZLAB |
Zai Lab Ltd
|
3,369,034 | $64,011,646 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,288,053 | $47,799,646 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,222,080 | $45,730,233 | |
| 8 | CYTK |
Cytokinetics Inc
This page
|
457,907 | $39,009,097 |
All Filings in CYTK
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,009,097 | 457,907 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $41,691,765 | 632,556 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $34,322,147 | 540,166 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $28,519,898 | 518,921 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,234,136 | 582,147 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,703,398 | 390,729 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $710,304 | 15,100 | Call | Sole | 2025-02-13 | |
| 2024-12-31 | $19,484,391 | 414,209 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $48,110,409 | 911,182 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $797,280 | 15,100 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $5,418 | 100 | Call | Sole | 2024-08-13 | |
| 2024-06-30 | $46,262,243 | 853,862 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $175,275 | 2,500 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $22,400,846 | 319,510 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,687,926 | 92,082 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $292,215 | 3,500 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $6,111,468 | 73,200 | Call | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||